Investor Relations
Marrone Bio Innovations Inc. (MBI) (NASDAQ: MBII) provides biological based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. As a leader in alternatives to conventional pesticides, MBII has a proven go-to-market strategy and remains on the cutting edge of developing the types of biological products in which today’s farmers are increasingly interested.
December 3, 2020
Marrone Bio Innovations will present at the Canaccord Genuity AgriFood Tech Innovation Virtual Forum at 1:30 p.m. Eastern Time
August 2020
Newly appointed CEO, Kevin Helash, shares his background, what brought him to Marrone Bio Innovations and insights on the company's Q2 earnings results.
Presentations & Interviews
January 6, 2021
MBII Investor Primer – January 2021
December 3, 2020